HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 80.84 +3.02 (3.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.82 | 52 Week High | $18.39 | |||
| Open | $77.43 | 52 Week Low | $6.96 | |||
| Day High | $81.19 | P/E | N/A | |||
| Day Low | $76.82 | EPS | $-0.58 | |||
| Volume | 1,751,209 | |||||
